RBM3 and neoplasm: Tumour-specific RBM3 protein expression could be evaluated in TURB specimens from 141/145 (97.2%) cases, in cystectomy specimens from 89/135 (65.9%) cases and in lymph node metastases from 25/27 (92.6%) cases.